Wie hoch ist der Preis für Microbix Biosystems Inc. (MBX)

Preis für Microbix Biosystems Inc. (MBX) ist $0.20917201

Wie hoch ist die Marktkapitalisierung für Microbix Biosystems Inc. (MBX)

Marktkapitalisierung für Microbix Biosystems Inc. (MBX) ist $28.76M

Microbix Biosystems Inc. (MBX) EPS

Microbix Biosystems Inc. is a life science enterprise dedicated to advancing human health globally, including markets across North America and Europe. Established in 1988 and headquartered in Mississauga, Canada, the company specializes in developing and marketing unique biological and technological products. A significant part of its business involves producing essential biological reagents for the diagnostic industry. This encompasses antigens vital for immunoassays, alongside its distinctive Quality Assessment and Proficiency (QAP) products. These QAPs are instrumental for clinical laboratories, providing support for proficiency testing, the development and validation of diagnostic assays, and optimizing routine lab operations. Furthermore, Microbix applies its deep biological knowledge and infrastructure to create additional proprietary offerings. Among these are DxTM, a viral transport medium crucial for stabilizing patient specimens prior to laboratory analysis, and Kinlytic Urokinase, a biopharmaceutical thrombolytic drug employed to treat blood clots. The company channels its QAP sales to accreditation organizations, diagnostic companies, and clinical laboratories via an extensive network of regional distributors.

Jahr	EPS	ändert
Nicht genügend Daten für die angegebenen Daten.

Jahr

EPS

ändert

Nicht genügend Daten für die angegebenen Daten.

Unternehmen	EPS	EPS-Differenz	Land
Vertex Pharmaceuticals Incorporated VRTX.US	$17.32	-	US
Moderna, Inc. MRNA.US	$-7.98	-	US
Argenx SE ARGX.US	$27.74	-	NL
CSL Limited CSL.AX	$2.98	-	AU
Lonza Group AG LONN.SW	-	-	CH

Unternehmen

EPS

EPS-Differenz

Land